Stay Calm And Quickly Carry On: Five Takeaways As China FDA Builds Capabilities

Growing its reviewers from 120 to 800 in a short time, the China FDA is now struggling with its very existence. After a productive year filled with over 30 new drug approvals, China's top drug regulatory agency, in its first annual report since massive regulatory reforms were announced, highlights five major trends to watch in 2018.